BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Rayens E, Norris KA, Cordero JF. Mortality Trends in Risk Conditions and Invasive Mycotic Disease in the United States, 1999-2018. Clin Infect Dis 2021:ciab336. [PMID: 33876235 DOI: 10.1093/cid/ciab336] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 10.0] [Reference Citation Analysis]
Number Citing Articles
1 Rayens E, Rayens MK, Norris KA. Demographic and Socioeconomic Factors Associated with Fungal Infection Risk, United States, 2019. Emerg Infect Dis 2022;28. [PMID: 36149028 DOI: 10.3201/eid2810.220391] [Reference Citation Analysis]
2 Rayens NT, Rayens EA, Tighe RM. Co-occurrence of pneumoconiosis with COPD, pneumonia and lung cancer. Occup Med (Lond) 2022:kqac079. [PMID: 35932472 DOI: 10.1093/occmed/kqac079] [Reference Citation Analysis]
3 Wen SR, Yang ZH, Dong TX, Li YY, Cao YK, Kuang YQ, Li HB. Deep Fungal Infections Among General Hospital Inpatients in Southwestern China: A 5-Year Retrospective Study. Front Public Health 2022;10:842434. [PMID: 35419337 DOI: 10.3389/fpubh.2022.842434] [Reference Citation Analysis]
4 Carvalhaes CG, Klauer AL, Rhomberg PR, Pfaller MA, Castanheira M, Hanson KE. Evaluation of Rezafungin Provisional CLSI Clinical Breakpoints and Epidemiological Cutoff Values Tested against a Worldwide Collection of Contemporaneous Invasive Fungal Isolates (2019 to 2020). J Clin Microbiol. [DOI: 10.1128/jcm.02449-21] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
5 Rayens E, Norris KA. Prevalence and Healthcare Burden of Fungal Infections in the United States, 2018. Open Forum Infect Dis 2022;9:ofab593. [PMID: 35036461 DOI: 10.1093/ofid/ofab593] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 8.0] [Reference Citation Analysis]
6 Ward RA, Aghaeepour N, Bhattacharyya RP, Clish CB, Gaudillière B, Hacohen N, Mansour MK, Mudd PA, Pasupneti S, Presti RM, Rhee EP, Sen P, Spec A, Tam JM, Villani AC, Woolley AE, Hsu JL, Vyas JM. Harnessing the Potential of Multiomics Studies for Precision Medicine in Infectious Disease. Open Forum Infect Dis 2021;8:ofab483. [PMID: 34805429 DOI: 10.1093/ofid/ofab483] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
7 Lawal IO, Mokoala KMG, Kgatle MM, Dierckx RAJO, Glaudemans AWJM, Sathekge MM, Ankrah AO. Radionuclide Imaging of Invasive Fungal Disease in Immunocompromised Hosts. Diagnostics (Basel) 2021;11:2057. [PMID: 34829403 DOI: 10.3390/diagnostics11112057] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
8 Moyes DL, Guimarães AJ, Figueiredo RT. Editorial: Immunity to Fungal Infections: Insights From the Innate Immune Recognition and Antifungal Effector Mechanisms. Front Microbiol 2021;12:714013. [PMID: 34335552 DOI: 10.3389/fmicb.2021.714013] [Reference Citation Analysis]